3Aapro MS,Bohlius J,Cameron DA,et al.2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours[J].Eur J Cancer,2011,47(1):8-32.
4Smith TJ,Khatchereessian J,Lyman GH,et al.2006 update of recommendations for the use of white blood cell growth factors:an evidence-based clinical practice guideline[J].J Clin Oncol,2006,24(19):3187-3205.
5National Comprehensive Cancer Network.Myeloid Growth Factors vl.2013[EB/OL].[2013-08-01].http://www.nccn.org.
